Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Medical Device Network on MSN20h
FDA approves GT Metabolic Solutions’ 50mm magnet in MagDI System
The MagDI System is a self-aligning, incisionless, sutureless and staple-free technology for surgical linkage.
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
India Today on MSN1d
Mankind Pharma launches generic for popular diabetes drug at one-tenth the cost
Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...
The Miami Times1d
Anti-obesity meds aren't all created equally
The new FDA-approved weight loss medicines have changed the game for people with obesity, offering millions of Americans a ...